Last reviewed · How we verify
NCT01816854
Endovascular Treatment of Atherosclerotic Lesions in the SFA Using the Sinus-superflex-635 Stent
trial testing Stenting in Atherosclerotic Heart Disease in 117 participants. Completed in 29 March 2017.
29 March 2017
Quick facts
| Lead sponsor | be Medical |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 117 |
| Start date | 8 October 2012 |
| Primary completion | 29 March 2017 |
| Estimated completion | 29 March 2017 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Stenting
Conditions studied
- Atherosclerotic Heart Disease — all drugs for Atherosclerotic Heart Disease →
Sponsor
be Medical
Who can join
18 and older, any sex, with Atherosclerotic Heart Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this prospective study, a newly developed self-expanding nitinol stent is evaluated for the treatment of atherosclerotic lesions in the superficial femoral artery and proximal popliteal artery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01816854
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Stenting
Trials testing the same drug.
- NCT07010354 — An Observational Study to Evaluate Safety, Performance, and Clinical Benefit of BeFlow · recruiting
- NCT04192760 — Culotte Versus DK-CRUSH Technique in Non-left Main Coronary Bifurcation Lesions · NA · unknown
- NCT03770650 — IVUS-guided DK Crush Stenting Technique for Patients With Complex Bifurcation Lesions · NA · active not recruiting
- NCT04571541 — Endoscopic Management of Esophageal Wall Defects · completed
- NCT01270139 — Plasmonic Nanophotothermal Therapy of Atherosclerosis · NA · completed
Other recruiting trials for Atherosclerotic Heart Disease
Currently open trials in the same condition.
- NCT06932874 — Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronar · Phase 4 · recruiting
- NCT00410241 — ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study · active not recruiting
Other be Medical trials
Trials by the same sponsor.
- NCT03810677 — Treatment of Varicose Veins With the ELVeS® Radial® 2ring Slim Fiber. Are There Limitations? · completed
- NCT03346577 — Endovascular Treatment of Peripheral Artery Disease · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01816854 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by be Medical
- Last refreshed: 20 December 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01816854.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing